0001493152-26-023928
SEC filingQ1 revenue grew modestly to $899K amid PHEXX price increases and network expansion, generating $2.3M free cash flow from strong operating collections, but operating losses widened to $4.6M due to absent prior-year gains and higher costs, signaling persistent liquidity pressures.
Revenue reached $899K in Q1 FY2026, up 6.4% from $845K prior year, as PHEXX benefited from a January 2026 price increase following heavy wholesaler purchases in December 2025, while SOLOSEC contributed to the topline amid network expansion. This growth preserved gross profit at $489K (54.4% margin, up slightly from 1.9% YoY), demonstrating pricing power and cost discipline at the gross level despite volume softness in PHEXX.
Profitability deteriorated sharply, with operating income flipping to a $4.6M loss (-508% margin) from a $327K profit. This swing reflects the normalization after one-time R&D vendor settlements in the prior period, compounded by higher operating costs as the company invests in commercialization without offsetting non-recurring gains. Net income followed to a $5.5M loss from $956K profit, with diluted EPS at -$0.04, underscoring other income/expense pressures from interest and fair value adjustments on financial instruments tied to capital raises.
Looking forward, the company anticipates continued net losses from lean operations at 2025 levels, potentially with marketing upticks if funded. Future filings may carry going concern explanatory paragraphs linked to liquidity strains, debt restructuring, and commercialization funding gaps. Investors should track Nasdaq relisting progress, international approvals, and PHEXX GLP-1 combo initiatives as potential catalysts amid fiscal constraints.